Inventor · disambiguated record
Luca Gianni
Also filed as: GIANNI LUCA
6 granted patents·11 pending applications·52 citations·filing 1994–2025
77Inventor score
Files withHOFFMANN LA ROCHE7BRISTOL MYERS SQUIBB CO2PHARMA MAR SAU2BAKER JOFFRE B1GENOMIC HEALTH INC1
Top patents by PatentIndex Score
17 records- 0195US7871769B2Gene expression markers for predicting response to chemotherapyGENOMIC HEALTH INC·Filed 2005·Granted Jan 18, 2011·47 cites·22 claims
- 0279US2022282337A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0378US2025340948A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0478US2022170115A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0576US2022090212A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0670US2020199690A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0769US9605318B2Gene expression markers for predicting response to chemotherapyBAKER JOFFRE B·Filed 2010·Granted Mar 28, 2017·1 cites·18 claims
- 0866US2018274038A1Identification of patients in need of pd-l-1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 0961US2016333414A1Identification of patients in need of pd-l1 inhibitor cotherapyHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1047US6927211B2Method for reducing toxicity of combined chemotherapiesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 9, 2005·0 cites·14 claims
- 1143US2009311249A1Capecitabine Combination TherapyGIANNI LUCA·Filed 2007·Application pending·0 cites
- 1242US6906040B2Method for reducing toxicity of combined chemotherapiesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jun 14, 2005·0 cites·3 claims
- 1341US7700613B2Use of 7-t-butoxyiminomethylcamptothecin for the preparation of a medicament for the treatment of uterine neoplasmsSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Apr 20, 2010·0 cites·5 claims
- 1439US2007082856A1Combination therapy comprising the use of et-743 and doxorubicin for treating cancerPHARMA MAR SAU·Filed 2004·Application pending·0 cites
- 1535US2002049169A1Method for reducing toxicity of combined chemotherapiesFiled 2001·Application pending·0 cites
- 1633US2007128201A1Combined use of ecteinascidin-743 and platinum antineoplastic compoundsPHARMA MAR SAU·Filed 2004·Application pending·0 cites
- 1729US5637572AUse of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosisPOLICLINICO SAN MATTEO ISTITUT·Filed 1994·Granted Jun 10, 1997·4 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Luca Gianni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →